Grace Lu-Yao, PhD, Associate Director of Population Science at the Sidney Kimmel Cancer Center – Jefferson Health (SKCC), has been honored with the International Society of Geriatric Oncology (SIOG) 2018 Nursing and Allied Health (NAH) Investigator Award at the SIOG 2018 Annual Conference.
This award recognizes significant contributions from new investigators in geriatric oncology nursing and allied professionals at the international level. Dr. Lu-Yao was selected for the outstanding quality of her work.
She presented her award-winning abstract, “Relationship between polypharmacy status and healthcare utilization in geriatric oncology patients undergoing chemotherapy,” at the SIOG Annual Conference, which was held in Amsterdam, Nov. 16-18. The study is the largest population-based study to quantify healthcare utilization among geriatric oncology patients within six months of chemotherapy and how the number of prescriptions patients were taking before chemotherapy affects post-chemotherapy utilization.
Dr. Lu-Yao, who is also Vice Chair of Population Science in the Department of Medical Oncology, joined SKCC in 2016 and established the Geriatric Oncology Research Working Group with the overarching goal to formulate innovative clinical algorithms and develop interventions to improve geriatric oncology care.
She also leads the Transdisciplinary Integration of Population Science (TIPS) at SKCC, a mechanism that has successfully integrated population science into the cancer center’s five existing research programs. TIPS has increased collaboration among clinical, basic, and population science researchers, thus maximizing efforts to reduce disease risk, incidence, and death from cancer on a local and national scale.
Dr. Lu-Yao is an accomplished cancer epidemiologist with expertise in outcomes research, comparative effectiveness studies, and clinical epidemiology. Many of her research findings on cancer surveillance, screening, and treatment for prostate cancer have provided benchmark references and have been included in professional guidelines. Dr. Lu-Yao’s findings have raised the level of clinical awareness regarding over-diagnosis and over-treatment for prostate cancer.